Lv1
58 积分 2023-10-17 加入
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
1天前
待确认
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
1天前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1天前
已完结
Molecular Insights and Risk Factors Associated with Small and Non-small Cell Lung Cancer
6天前
已完结
Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations
7天前
已关闭
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
19天前
已完结
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
20天前
已关闭
Efficacy, suicidality, tolerability, and acceptability of selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors for children and adolescents with anxiety disorders: a systematic review and meta-analysis
27天前
已完结
Efficacy, suicidality, tolerability, and acceptability of selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors for children and adolescents with anxiety disorders: a systematic review and meta-analysis
28天前
已完结
Three-Year Follow-Up of children and adolescents with OCD Who Did Not Respond to Initial Cognitive-Behavioral Therapy (CBT): Outcomes of Continued CBT vs. Sertraline
28天前
已完结
皖公网安备34019202002308
